#USA #Veeva Systems #AstraZeneca #AI Innovations #Copenhagen

Veeva Summit: Shaping the Future of Commercial Excellence

The Veeva Commercial Summit Europe is set to take place from November 18-19 in Copenhagen, Denmark, featuring prominent leaders from major biopharmaceutical companies such as AstraZeneca, Bristol Myers Squibb, and Roche. The summit promises insightful discussions and demonstrations on how AI technologies can revolutionize customer engagement and streamline medical and commercial processes in the life sciences industry.

Gathering of Industry Leaders

This event is one of the largest gatherings for life sciences executives in Europe, expected to attract over 1,200 experts from across the sector. Participants will benefit from more than 100 presentations focused on successful customer strategies and notable innovations utilizing Veeva’s Commercial Cloud and Data Cloud services.

AI-Driven Strategies for Enhanced Customer Engagement

Several companies will share groundbreaking approaches during the summit:

• - Agentic Commercialization: Grünenthal and Roche will discuss how they are scaling agent-based customer engagement to create connected health care professional (HCP) experiences across various channels, including field sales, digital platforms, and events.

• - Enhanced Personalization: GSK and other leading biopharma companies will illustrate how 'Agentic CRM' is enabling smarter and more personalized interactions with medical professionals, tailoring content to fit their unique needs.

• - Identifying Treatment Barriers: BeOne Medicines will highlight the use of dialogue-centered AI on branding websites to pinpoint and eliminate treatment obstacles for both HCPs and patients.

• - Efficiency in Content Approval: Bristol Myers Squibb will showcase innovations that expedite the approval process for promotional materials, enhancing productivity through agent-based MLR (medical, legal, regulatory) frameworks.

Building a Strong Data Foundation

AstraZeneca will present how access data for medical professionals is being leveraged to improve target audience engagement in the field, aiming at greater revenue growth. Additionally, Bayer and Server will discuss their initiative to establish a trusted global data foundation to scale AI capabilities and enhance decision-making across markets.

Committing to Meaningful Medical Outcomes

Companies such as Biogen and UCB will share how medical insights can be transformed into actionable strategies to improve decision-making and patient outcomes. Bayer, Novo, and One MSL will explore how the increasing adoption of AI among medical professionals is reshaping scientific collaboration strategies.

Developing the Future of Life Sciences

Chris Moore, President of Veeva Europe, expressed, "The pace of innovation in life sciences is accelerating, with AI creating new opportunities for meaningful and timely interaction with medical professionals and patients. The Veeva Summit provides a platform for leaders to share insights and ideas as the industry transitions toward an ‘Agentic Commercial’ model."

This event is exclusively open to professionals in the life sciences sector, with registration available at veeva.com/eu/Summit to secure a spot.

About Veeva Systems

Veeva is the leading industry cloud for life sciences, providing applications, data, and consulting to over 1,500 customers—from the world’s largest pharmaceutical firms to emerging biotech organizations. Committed to innovation and product quality, Veeva aligns stakeholder interests, including customers, employees, shareholders, and the industries it serves. More information can be found at veeva.com/eu.

This article contains forward-looking statements regarding Veeva’s products, services, and the expected outcomes from their use. Actual results may differ significantly, and Veeva does not commit to updating any such statements.